187 related articles for article (PubMed ID: 30220006)
1. Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single center.
Falhammar H; Kjellman M; Calissendorff J
Endocrine; 2018 Dec; 62(3):566-575. PubMed ID: 30220006
[TBL] [Abstract][Full Text] [Related]
2. Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY.
Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Calatayud M; Hanzu F; Mora M; Vicente A; Blanco Carrera C; De Miguel Novoa P; López García MDC; Manjón-Miguélez L; Rodríguez de Vera P; Del Castillo Tous M; Barahona San Millán R; Recasens M; Tomé Fernández-Ladreda M; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Lamas C
J Endocrinol Invest; 2023 Apr; 46(4):805-814. PubMed ID: 36323983
[TBL] [Abstract][Full Text] [Related]
3. Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas.
Araujo-Castro M; Mínguez Ojeda C; García Centeno R; López-García MC; Lamas C; Hanzu FA; Mora M; Del Castillo Tous M; Rodríguez de Vera Gómez P; Parra Ramírez P; Alvarez-Escola C; Blanco Carrera C; Barahona San Millán R; Recasens M; Valdés N; Gracia Gimeno P; de Miguel Novoa P; Vicente A; Manjón L; García Sanz I; Michalopoulou T; Calatayud M
Endocr Relat Cancer; 2022 Dec; 29(12):645-655. PubMed ID: 36069783
[TBL] [Abstract][Full Text] [Related]
4. The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomas.
Ohmachi Y; Yamamoto M; Inaba Y; Makino S; Urai S; Matsumoto R; Bando H; Kanie K; Tsujimoto Y; Motomura Y; Sasaki Y; Oi-Yo Y; Yamamoto N; Suzuki M; Takahashi M; Iguchi G; Kanzawa M; Furukawa J; Shigemura K; Mizobuchi S; Ogawa W; Fukuoka H
Endocrine; 2024 May; 84(2):694-703. PubMed ID: 38206436
[TBL] [Abstract][Full Text] [Related]
5. Co-occurrence of pheochromocytoma and paraganglioma of the organ of Zuckerkandl resected simultaneously by laparoscopy: a rare case report and literature review.
Chang Z; Shang J; Yang S; Qin W; Cui H
J Int Med Res; 2023 Mar; 51(3):3000605231161211. PubMed ID: 36950957
[TBL] [Abstract][Full Text] [Related]
6. Preoperative α-blockade versus no blockade for pheochromocytoma-paraganglioma patients undergoing surgery: a systematic review and updated meta-analysis.
Wang J; Liu Q; Jiang S; Zhang J; He J; Li Y; Wang D
Int J Surg; 2023 May; 109(5):1470-1480. PubMed ID: 37037514
[TBL] [Abstract][Full Text] [Related]
7. Nonselective Compared With Selective α-Blockade Is Associated With Less Intraoperative Hypertension in Patients With Pheochromocytomas and Paragangliomas: A Retrospective Cohort Study With Propensity Score Matching.
Kong H; Li N; Yang XC; Nie XL; Tian J; Wang DX
Anesth Analg; 2021 Jan; 132(1):140-149. PubMed ID: 32675634
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas.
Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Hanzu F; Mora M; Vicente A; Blanco Carrera C; Miguel Novoa P; López García MDC; Lamas C; Manjón-Miguélez L; Del Castillo Tous M; Rodríguez de Vera P; Barahona San Millán R; Recasens M; Fernández-Ladreda MT; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Calatayud M
J Hypertens; 2024 Feb; 42(2):252-259. PubMed ID: 37851004
[TBL] [Abstract][Full Text] [Related]
9. Preoperative intravenous rehydration for patients with pheochromocytomas and paragangliomas: is it necessary? A propensity score matching analysis.
Kong H; Yang JN; Tian J; Li N; Zhang YX; Ye PC; Li XY; Zhang Z
BMC Anesthesiol; 2020 Nov; 20(1):294. PubMed ID: 33250060
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 producing pheochromocytoma/paraganglioma: case series from a tertiary referral centre for pheochromocytomas and paragangliomas.
Meijs AC; Schroijen MA; Snel M; Corssmit EPM
J Endocrinol Invest; 2021 Oct; 44(10):2253-2259. PubMed ID: 33715142
[TBL] [Abstract][Full Text] [Related]
11. Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatment.
Januszewicz M; Dobrowolski P; Januszewicz A; Warchoł-Celińska E; Jóźwik-Plebanek K; Motyl D; Kabat M; Pęczkowska M; Michałowska I; Ambroziak U; Toutounchi S; Gałązka Z; Courcelles L; Pappaccogli M; Eisenhofer G; Persu A; Lenders JWM; Kądziela J; Prejbisz A
Blood Press; 2021 Jun; 30(3):172-179. PubMed ID: 33586556
[TBL] [Abstract][Full Text] [Related]
12. Perioperative outcomes of pheochromocytoma/paraganglioma surgery preceded by Takotsubo-like cardiomyopathy.
Hain É; Chamakhi A; Lussey-Lepoutre C; Bertherat J; Baillard C; Manceau G; Puybasset L; Blacher J; Cholley B; Gimenez-Roqueplo AP; Dousset B; Amar L; Menegaux F; Gaujoux S
Surgery; 2022 Sep; 172(3):913-918. PubMed ID: 35589436
[TBL] [Abstract][Full Text] [Related]
13. Reduced uptake pattern on
de Jong MC; Pinto D; Parameswaran R
J Surg Oncol; 2023 Oct; 128(5):764-768. PubMed ID: 37403579
[TBL] [Abstract][Full Text] [Related]
14. Influence of duration of preoperative treatment with phenoxybenzamine and secretory phenotypes on perioperative hemodynamics and postoperative outcomes in pheochromocytoma and paraganglioma.
Yao Y; Guo Y; Fan J; Lin T; Wang L; Zhang S
Front Endocrinol (Lausanne); 2023; 14():1139015. PubMed ID: 37152936
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study.
Zhao L; Meng X; Mei Q; Fan H; Liu Y; Zhou X; Zhu H; Zhang S
Front Endocrinol (Lausanne); 2022; 13():877341. PubMed ID: 35721724
[TBL] [Abstract][Full Text] [Related]
16. Risk Predictors of Prolonged Hypotension After Open Surgery for Pheochromocytomas and Paragangliomas.
Kong H; Li N; Tian J; Li XY
World J Surg; 2020 Nov; 44(11):3786-3794. PubMed ID: 32691105
[TBL] [Abstract][Full Text] [Related]
17. Clinical Presentation and Perioperative Management of Pheochromocytomas and Paragangliomas: A 4-Decade Experience.
Uslar T; San Francisco IF; Olmos R; Macchiavelo S; Zuñiga A; Rojas P; Garrido M; Huete A; Mendez GP; Cortinez I; Zemelman JT; Cifuentes J; Castro F; Olivari D; Domínguez JM; Arteaga E; Fardella CE; Valdés G; Tagle R; Baudrand R
J Endocr Soc; 2021 Oct; 5(10):bvab073. PubMed ID: 34377881
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma.
Lopez C; Bima C; Bollati M; Bioletto F; Procopio M; Arata S; Candela DG; Beccuti G; Ghigo E; Maccario M; Parasiliti-Caprino M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982228
[TBL] [Abstract][Full Text] [Related]
19. Non-Selective Alpha-Blockers Provide More Stable Intraoperative Hemodynamic Control Compared with Selective Alpha1-Blockers in Patients with Pheochromocytoma and Paraganglioma: A Single-Center Retrospective Cohort Study with a Propensity Score-Matched Analysis from China.
Yang Y; Zhang J; Fang L; Jia X; Zhang W
Drug Des Devel Ther; 2022; 16():3599-3608. PubMed ID: 36262769
[TBL] [Abstract][Full Text] [Related]
20. [Strategy of reoperation for pheochromocytoma and paraganglioma].
Liu L; Qin YC; Wang GL; Zhang SD; Hou XF; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):793-797. PubMed ID: 34393247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
